Global Etomidate Market Size, Share and Trends Analysis Report, By Application (Reduction Of Dislocated Joints, Tracheal Intubation, Cardioversion And Electroconvulsive Therapy), Forecast Period (2022-2028)

The global etomidate market is anticipated to grow at a CAGR of 2.8% during the forecast period (2022-2028). The widespread use of anesthesia for a number of medical procedures has accelerated the global etomidate market. Since etomidate can be utilized as an effective sedative drug, the pharmaceutical sector has been the primary buyer. Conscious sedation is widely used in the medical community, which expands the market’s potential. Etomidate is given to patients with traumatic brain injuries as they aid to maintain arterial pressure by regulating intracranial pressure.

 

The pace of human metabolism can be accelerated by providing etomidate in controlled doses. As a result, these chemicals are injected into the body to speed up metabolism and the recovery process following surgery.

 

Some major players in the market include Darmstadt, Pfizer Inc., Emcure Pharmaceuticals Ltd, Merck KGaA, Mylan N.V., Zydus Lifesciences Ltd, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

 

Company’s Product Portfolio

Emcure Pharmaceuticals Ltd offers Etomidate (Amidate) Injection, It’s a nonpyrogenic, sterile fluid. Each milliliter includes 2 mg of etomidate USP and 35 percent v/v propylene glycol. The pH level is 6.0. (4.0 to 7.0). It is used to induce general anesthesia through intravenous injection.

 

Mylan N.V. offers a generic version of Amidate Injection which got approval from the U.S. Food and Drug Administration. It’s for Etomidate Injection USP, 2 mg/mL, packaged in 40 mg/20 mL single-use vials, according to the Abbreviated New Drug Application (ANDA).

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Darmstadt, Pfizer Inc., Emcure Pharmaceuticals Ltd, Merck KGaA, Mylan N.V., Zydus Lifesciences Ltd, among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Etomidate Market Report by Segment

By Application

• Reduction Of Dislocated Joints
• Tracheal Intubation
• Cardioversion and Electroconvulsive Therapy

 

Global Etomidate Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa